Publication | Closed Access

Risk of bleeding and arterial thromboembolism in patients with non-valvular atrial fibrillation either maintained on a vitamin K antagonist or switched to a non-vitamin K-antagonist oral anticoagulant: a retrospective, matched-cohort study

ThrombosisMatched-cohort StudyVenous ThrombosisCardiovascular DiseaseAtherosclerosisMedicineNon-valvular Atrial FibrillationFibrinolysisPharmacotherapyCoagulopathyPublic HealthPlatelet AntagonistStrokeAnticoagulantCardiologyEpidemiologyVitamin K Antagonist